American Heart Journal
Volume 158, Issue 4 , Pages 680-687 , October 2009

Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery

  • Jason N. Katz, MD

      Affiliations

    • University of North Carolina School of Medicine, Chapel Hill, NC
    • Duke Clinical Research Institute, Durham, NC
    • Corresponding Author InformationReprint requests: Jason N. Katz, MD, 160 Dental Circle, 6th floor Burnett-Womack Building, UNC Center for Heart and Vascular Care, CB#7075, Chapel Hill, NC 27599-7875.
    • ,
  • Amanda L. Stebbins, PhD

      Affiliations

    • Duke Clinical Research Institute, Durham, NC
    • ,
  • John H. Alexander, MD, MHS

      Affiliations

    • Duke Clinical Research Institute, Durham, NC
    • Duke University Medical Center, Durham, NC
    • ,
  • Harmony R. Reynolds, MD

      Affiliations

    • New York University, New York, NY
    • ,
  • Karen S. Pieper, MS

      Affiliations

    • Duke Clinical Research Institute, Durham, NC
    • ,
  • Witold Ruzyllo, MD

      Affiliations

    • National Institute of Cardiology, Warsaw, Poland
    • ,
  • Karl Werdan, MD

      Affiliations

    • Martin-Luther-University Halle-Wittenberg, Halle/Saale, Germany
    • ,
  • Alexander Geppert, MD

      Affiliations

    • Wilhelminenhospital, Vienna, Austria
    • ,
  • Vladimir Dzavik, MD

      Affiliations

    • University of Toronto, Toronto, Ontario, Canada
    • ,
  • Frans Van de Werf, MD, PhD

      Affiliations

    • University of Leuven, Leuven, Belgium
    • ,
  • Judith S. Hochman, MD

      Affiliations

    • New York University, New York, NY
    • ,
  • for the TRIUMPH Investigators

Received 30 March 2009 ,Accepted 10 August 2009.

References 

  1. Babaev A, Frederick PD, Pasta DJ, et al. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA. 2005;294:448–454
  2. Fang J, Mensah GA, Alderman MH, et al. Trends in acute myocardial infarction complicated by cardiogenic shock, 1979-2003, United States. Am Heart J. 2006;152:1035–1041
  3. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA. 2006;295:2511–2515
  4. Sleeper LA, Jacobs AK, LeJemtel TH, et al. A mortality model and severity scoring system for cardiogenic shock complicating acute myocardial infarction. Circulation. 2000;102:II–795
  5. Katayama T, Nakashima H, Takagi C, et al. Predictors of mortality in patients with acute myocardial infarction and cardiogenic shock. Circ J. 2005;69:83–88
  6. Tarantini G, Ramondo A, Isabella G, et al. Pressure response to vasopressors and mortality after direct angioplasty for cardiogenic shock. Int J Cardiol. 2004;94:197–202
  7. Mehta RH, Califf RM, Yang Q, et al. Impact of initial heart rate and systolic blood pressure on relation of age and mortality among fibrinolytic-treated patients with acute ST-elevation myocardial infarction presenting with cardiogenic shock. Am J Cardiol. 2007;99:793–796
  8. Klein LW, Shaw RE, Krone RJ, et al. Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model. Am J Cardiol. 2005;96:35–41
  9. Singh M, White J, Hasdai D, et al. Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock. Insights from the GUSTO-1 trial. J Am Coll Cardiol. 2007;50:1752–1758
  10. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med. 1999;341:625–634
  11. Webb JG, Lowe AM, Sanborn TA, et al. Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. J Am Coll Cardiol. 2003;42:1380–1386
  12. Bengtson JR, Kaplan AJ, Pieper KS, et al. Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. J Am Coll Cardiol. 1992;20:1482–1489
  13. The TRIUMPH Investigators . Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA. 2007;297:1657–1666
  14. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
  15. Stone CJ, Koo CY. In: Proc Stat Comp Sect Am Statist Assoc. Washington, DC: Amer Statist Assoc; 1985;p. 45–48
  16. Dzavik V, Cotter G, Reynolds HR, et al. Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study. Eur Heart J. 2007;28:1109–1116
  17. Schreiber W, Herkner H, Koreny M, et al. Predictors of survival in unselected patients with acute myocardial infarction requiring continuous catecholamine support. Resuscitation. 2002;55:269–276
  18. Valente S, Lazzeri C, Vecchio S, et al. Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock. Int J Cardiol. 2007;114:176–182
  19. Müllner M, Urbanek B, Havel C, et al. Vasopressors for shock. Cochrane Database Syst Rev. 2004;CD003709
  20. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation. 2004;110:588–636
  21. Samadi A, Le Feuvre C, Allali Y, et al. Medium-term survival after primary angioplasty for myocardial infarction complicated by cardiogenic shock after the age of 75 years. Arch Cardiovasc Dis. 2008;101:175–180
  22. Marenzi G, Moltrasio M, Assanelli E, et al. Impact of cardiac and renal dysfunction on inhospital morbidity and mortality of patients with acute myocardial infarction undergoing primary angioplasty. Am Heart J. 2007;153:755–762
  23. Koreny M, Karth GD, Geppert A, et al. Prognosis of patients who develop acute renal failure during the first 24 hours of cardiogenic shock after myocardial infarction. Am J Med. 2002;112:115–119
  24. Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients. A multinational, multicenter study. JAMA. 2005;294:813–818
  25. Vis MM, Sjauw KD, van der Schaaf RJ, et al. In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes. Am Heart J. 2007;154:1184–1190
  26. Picard MH, Davidoff R, Sleeper LA, et al. Echocardiographic predictors of survival and response to early revascularization in cardiogenic shock. Circulation. 2003;107:279–284
  27. Hochman JS. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation. 2003;107:2998–3002

 Marc A. Pfeffer, MD, PhD served as guest editor on this manuscript.

PII: S0002-8703(09)00616-4

doi: 10.1016/j.ahj.2009.08.005

American Heart Journal
Volume 158, Issue 4 , Pages 680-687 , October 2009

Article Tools

* Image Usage & Resolution